34th Annual Report for the Financial Year 2025-26

August 27, 2026 Department of Corporate Services, BSE Limited P J Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 530125 Dear Sir, Sub: Annual Report for the financial year 2025-26 and Notice of 34th Annual General Meeting The 34th Annual General Meeting (AGM) of the Company will be held on Wednesday, September 23, 2026 at 01:00 P. M. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). The Register of Members and the Share Transfer books of the Company will remain closed from Sunday, September 20, 2026 to Tuesday, September 22, 2026 (both days inclusive). The Remote E-voting period begins on Sunday, September 20, 2026 at 9:00 A.M. (IST) and ends on Tuesday, September 22, 2026 at 5:00 P.M (IST). The Annual Report containing the Notice is also uploaded on the Company’s website: www.samratpharmachem.com This is for your information and records. Thanking you. Yours faithfully, For Samrat Pharmachem Limited Nishant Kankaria Company Secretary & Compliance Officer 34th Annual Report 2025-2026 IODINE EXTRACTION PROCESS Two Sustainable Paths – Chile & Japan 1. IODINE EXTRACTION FROM 2. IODINE EXTRACTION & RECYCLING, ATACAMA DESERT, CHILE CHIBA, JAPAN Source: Caliche Sedimentary Rock Sources: Brine & Recycling Technologies A. IODINE EXTRACTION FROM BRINE 1 CALICHE BLASTING IN THE DESERT Caliche (iodine-containing 1 BRINE 2 BLOW-OUT 3 PURIFICATION 4 IODINE 5 PURIFICATION rock) is drilled and blasted COLLECTION & SEPARATION EXTRACTION & DRYING in the desert to break it into smaller pieces. Brine from Brine is depressurized Removal of Iodine is extracted Iodine is natural gas (blow-out) and suspended from purified purified, dried wells or separated from solids and other brine using and packaged to 2 COLLECTING AND marine wells natural gas impurities. adsorption, high purity HEAP LEACHING is collected. and solids. solvent extraction specifications. The blasted rock is collected or ion exchange. and crushed. It is then stacked in heaps and leached with water (sometimes with additives) to extract iodine into solution. 3 TRANSPORT TO PLANT & ADDITION OF KEROSENE AND OTHER REAGENTS The iodine-rich solution is transported to the plant B. IODINE RECOVERY & RECYCLING (CIRCULAR ECONOMY) and mixed with kerosene and other reagents (to extract and condition the iodine). 1 SOURCES 2 COLLECTION & 3 IODINE RECOVERY PRE-TREATMENT 4 Iodine-containing Advanced extraction CONCENTRATION OF waste from Segregation, technologies (solvent IODINE IN THE BRINE pharmaceuticals, dissolution and extraction, ion The iodine-rich organic phase X-ray contrast media, removal of exchange, adsorption is back-extracted or stripped seaweed ash, impurities. or oxidation) with an alkaline solution to recover iodine. industrial wastewater, (brine). This transfers iodine into the brine. The brine is and other industries. then concentrated to increase iodine content before prilling. 5 TO PRILL TOWER The treated solution is pumped to a prill tower, where it is atomized into fine droplets. 6 REUSE & RESOURCE 5 DRYING & 4 PURIFICATION CIRCULATION CRYSTALLIZATION High purity iodine Iodine is dried and Multi -stage returned to industries. crystallized to purification to 6 Making Iodine Prills Z sue sro ta iw naa bs lt ee & r se pq eu ci ir fie cd a tion. a pc uh rii te yv ie o dh ii ng eh . As the droplets fall, they resource cycle. solidify into spherical iodine prills, which are collected, washed, and dried for further use. END PRODUCT END PRODUCT High Purity Crystalline Iodine High Purity Crystalline Iodine (≥ 99.5% I₂) (≥ 99.5% I₂) KEY USES BENEFITS Reliable supply from natural brine Advanced extraction & recycling technologies High purity, consistent quality Pharmaceuticals Iodized Salt Electronics Catalysts Advanced Resource sustainability & circular economy Materials Supporting critical industries and global health Two paths. One essential element for a better tomorrow. Nature's gift. Science's responsibility. Samrat Pharmachem Limited 34ᵗʰ Annual Report FY 2025-26 Table of Contents Board of Directors & General Information 2 Notice of Annual General Meeting 3 Directors’ Report 19 Management Discussion and Analysis 40 Corporate Governance Report 43 Independent Auditors’ Report 64 Financial Statement 76 Samrat Pharmachem Limited 34ᵗʰ Annual Report FY 2025-26 BOARD OF DIRECTORS Name Designation DIN Mr. Lalit Mehta Chairman & Managing Director 00216681 Mr. Rajesh Mehta Executive Director 00216731 Mr. Megh Mehta Executive Director 07287394 Ms. Piyush Dharod Independent Director, Non-Executive 11119391 Mr. Manishkumar Pipalia Independent Director, Non-Executive 00376313 Mr. Sachin Kothary Independent Director, Non-Executive 10470497 Ms. Megha Jain Independent Director, Non-Executive 10727038 REGISTERED OFFICE & FACTORY Plot No. A2/3444-3445, GIDC, Phase 4, Ankleshwar - 393002, Gujarat, India Tel: +91-7045456789, 7046456789 Email: contact@samratpharmachem.in Web: www.samratpharmachem.com CIN: L24230GJ1992PLC017820 CORPORATE OFFICE 701/702, Business Square, M. A. Road, Andheri (West), Mumbai - 400058, India Tel: +91-7507534567 / 8760345678 STATUTORY AUDITOR Shah & Savla LLP Chartered Accountants RNJ Corporate, Jawahar Road, Ghatkopar (East), Mumbai - 400077, India COMPANY SECRETARY & COMPLIANCE OFFICER Mr. Nishant Kankaria SECRETARIAL AUDITOR M/s. A. A. Mulla & Associates Company Secretaries 102 Sahajanand CHS Ltd., Plot No. 232, Sector 21, Nerul (East), Navi Mumbai - 400706, India BANKER ICICI Bank Limited DLH Plaza, S. V. Road, Andheri (West), Mumbai – 400058, India REGISTRARS & SHARE TRANSFER AGENT MUFG Intime India Private Limited C-101, Embassy 247, L. B. S. Marg, Vikhroli (West), Mumbai - 400083, India Tel: +91 22 49186000 Email: rnt.helpdesk@in.mpms.mufg.com Web: www.in.mpms.mufg.com CIN: U67190MH1999PTC118368 Samrat Pharmachem Limited 34ᵗʰ Annual Report FY 2025-26 NOTICE OF ANNUAL GENERAL MEETING NOTICE is hereby given that the THIRTY-FORTH ANNUAL GENERAL MEETING of SAMRAT PHARMACHEM LIMITED will be held on Wednesday, September 23, 2026 at 1.00 P.M. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) to transact the following businesses: ORDINARY BUSINESS 1. To receive, considerandadopttheAuditedStandalone FinancialStatementsofthe companyfortheyearendedMarch 31, 2026, together with Directors' and Auditors' Reports thereon. 2. ToappointaDirectorinplaceofMr.MeghMehta(DIN:07287394),whoretiresbyrotationand,beingeligible,offers himself for re-appointment. SPECIAL BUSINESS 3. Appointment of Statutory Auditor To consider and if thought fit, to pass with or without modification the following Resolution as an Ordinary Resolution: “RESOLVEDTHATpursuanttotheprovisionofSection139&142oftheCompaniesAct,2013&rulesmadetheir under of the Companies (Audit & Auditors) Rules, 2014 read with circulars issued thereunder from time to time and other applicable provisions, if any, (including any statutory modification(s) or re-enactment thereof for the time being inforce), and basedon therecommendationofthe AuditCommitteeand theBoard ofDirectorsoftheCompany,M/s. DivyeshJShah &Associates, [FRN Number:118227W (PeerReviewed)]beand is herebyappointedas theStatutory Auditors of the Company, to carry out Statutory Audit for a term of 5 (five) consecutive years, commencing from the financialyear2026-27untiltheconclusionofthe39thAnnualGeneralMeetingoftheCompanywhichwillbeheldfor the financial year 2030-31, on such remuneration including out of pocket expenses and applicable taxes as recommendedbytheAuditCommitteeandasmaybemutuallyagreedbetweentheBoardofDirectorsoftheCompany and the Auditors from time to time and the material terms of which are set out in the Explanatory Statement attached hereto.” “RESOLVED FURTHER THAT the Board of Directors be and is hereby authorised to avail or obtain from the StatutoryAuditors,suchotherservicesorcertificates,reports,oropinionswhichtheStatutoryAuditorsmaybeeligible to provide or issue under the Applicable Laws at a remuneration to be deter [Showing first 8,000 characters — download PDF for full document]